PulmCCM

PulmCCM

Share this post

PulmCCM
PulmCCM
Recurrent PE risk after long-term warfarin therapy remains high (PADIS-PE)
Copy link
Facebook
Email
Notes
More

Recurrent PE risk after long-term warfarin…

...
Jul 17, 2015

Share this post

PulmCCM
PulmCCM
Recurrent PE risk after long-term warfarin therapy remains high (PADIS-PE)
Copy link
Facebook
Email
Notes
More

Not long ago, doctors were taught that 6 months of anticoagulation was plenty for patients with unprovoked pulmonary embolism.

Read →
Comments
User's avatar
© 2025 PulmCCM LLC
Publisher Terms
Substack
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More